US Stock MarketDetailed Quotes

ADMA ADMA Biologics

Watchlist
  • 11.180
  • +0.230+2.10%
Close Jun 28 16:00 ET
  • 11.080
  • -0.100-0.89%
Post 19:56 ET
2.59BMarket Cap-559000P/E (TTM)

ADMA Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
84.94%-2.22M
114.79%8.8M
338.46%17.6M
190.22%11.99M
52.79%-6.06M
43.40%-14.72M
47.04%-59.51M
77.95%-7.38M
0.95%-13.28M
60.23%-12.83M
Net income from continuing operations
362.28%17.81M
57.15%-28.24M
-44.25%-17.64M
117.22%2.57M
53.72%-6.37M
72.85%-6.79M
8.02%-65.9M
26.54%-12.23M
15.88%-14.9M
27.19%-13.76M
Operating gains losses
27.78%23K
271.37%26.36M
6,168.96%26.25M
1,509.20%92.85K
-84.95%96
-99.73%18K
3,111.31%7.1M
197.93%418.65K
146.16%5.77K
-99.18%638
Depreciation and amortization
3.98%2.11M
17.14%8.33M
8.90%2.11M
12.38%2.09M
21.65%2.1M
27.84%2.03M
29.42%7.11M
27.55%1.94M
30.93%1.86M
30.04%1.72M
Other non cash items
-84.85%217K
19.59%6.29M
7.52%1.54M
-12.78%1.68M
21.10%1.64M
160.77%1.43M
199.71%5.26M
206.66%1.43M
327.20%1.92M
215.45%1.35M
Change In working capital
-95.73%-24.52M
44.64%-10.12M
99,563.79%3.6M
210.66%3.86M
-51.76%-5.06M
-9.33%-12.53M
64.62%-18.29M
99.98%-3.62K
-300.87%-3.49M
79.15%-3.33M
-Change in receivables
-101.58%-22.2M
-191.16%-11.92M
-27.79%3.9M
368.16%5.41M
-251.41%-10.21M
-473.67%-11.01M
185.22%13.07M
165.95%5.4M
-164.04%-2.02M
182.44%6.75M
-Change in inventory
-584.54%-4.83M
75.03%-9.63M
-2,571.51%-9.79M
92.07%-1.34M
131.82%2.2M
95.11%-705K
10.73%-38.56M
96.54%-366.46K
-16.74%-16.84M
-24.77%-6.93M
-Change in prepaid assets
-39.20%611K
232.65%841K
919.33%2.07M
84.32%-72.39K
-264.90%-2.17M
361.82%1.01M
79.34%-634K
-63.53%203.48K
44.12%-461.58K
-832.77%-593.52K
-Change in payables and accrued expense
174.92%1.22M
36.42%11.37M
249.94%7.65M
-99.21%126.09K
316.33%5.22M
-1,711.76%-1.63M
-14.06%8.33M
-150.28%-5.1M
16.67%15.94M
-11.63%-2.41M
-Change in other current liabilities
462.03%677K
-57.57%-791K
-68.14%-229.66K
-143.01%-268.34K
26.35%-106.01K
-68.37%-187K
-329.22%-502K
-222.55%-136.59K
-163.63%-110.42K
-341.89%-143.93K
Cash from discontinued investing activities
Operating cash flow
84.94%-2.22M
114.79%8.8M
338.46%17.6M
190.22%11.99M
52.79%-6.06M
43.40%-14.72M
47.04%-59.51M
77.95%-7.38M
0.95%-13.28M
60.23%-12.83M
Investing cash flow
Cash flow from continuing investing activities
-21.44%-2.36M
64.19%-4.98M
62.46%-1.41M
77.62%-756.56K
77.86%-872.23K
31.56%-1.95M
-2.96%-13.91M
-1.98%-3.75M
-21.22%-3.38M
11.96%-3.94M
Net PPE purchase and sale
-20.67%-2.35M
65.70%-4.77M
68.06%-1.2M
77.62%-756.56K
77.86%-872.23K
31.56%-1.95M
-2.96%-13.91M
-1.98%-3.75M
-21.22%-3.38M
11.96%-3.94M
Net intangibles purchase and sale
---15K
---210K
----
----
----
--0
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
-21.44%-2.36M
64.19%-4.98M
62.46%-1.41M
77.62%-756.56K
77.86%-872.23K
31.56%-1.95M
-2.96%-13.91M
-1.98%-3.75M
-21.22%-3.38M
11.96%-3.94M
Financing cash flow
Cash flow from continuing financing activities
-122.62%-1.45M
-135.82%-38.99M
-162.15%-38.99M
149.22%415.36K
175.10%239.61K
-101.38%-650K
-10.08%108.85M
16.58%62.74M
-110.29%-843.79K
-101.86%-319.04K
Net issuance payments of debt
--0
-145.64%-23.6M
-270,400.88%-23.58M
--0
33.71%-6.03K
-100.02%-10K
152,200.00%51.71M
-2.66%-8.72K
-6.94%-9.25K
-6.98%-9.09K
Net common stock issuance
----
--0
----
----
----
----
-46.64%64.65M
----
----
----
Proceeds from stock option exercised by employees
--1.03M
530.86%1.1M
-95.17%8.46K
--623.99K
--471.55K
--0
--175K
--175K
--0
----
Net other financing activities
-286.88%-2.48M
-114.68%-16.49M
-645.61%-15.42M
75.00%-208.64K
27.11%-225.91K
85.68%-640K
-12,290.32%-7.68M
-514,271.89%-2.07M
-36,390.77%-834.54K
---309.95K
Cash from discontinued financing activities
Financing cash flow
-122.62%-1.45M
-135.82%-38.99M
-162.15%-38.99M
149.22%415.36K
175.10%239.61K
-101.38%-650K
-10.08%108.85M
16.58%62.74M
-110.29%-843.79K
-101.86%-319.04K
Net cash flow
Beginning cash position
-40.65%51.35M
69.36%86.52M
112.45%74.16M
19.27%62.51M
-0.43%69.2M
69.36%86.52M
-8.64%51.09M
1.44%34.91M
23.59%52.42M
12.17%69.5M
Current changes in cash
65.20%-6.03M
-199.26%-35.17M
-144.18%-22.81M
166.50%11.64M
60.85%-6.69M
-194.04%-17.32M
833.30%35.43M
209.48%51.62M
-118.91%-17.51M
12.61%-17.09M
End cash Position
-34.51%45.33M
-40.65%51.35M
-40.65%51.35M
112.45%74.16M
19.27%62.51M
-0.43%69.2M
69.36%86.52M
69.36%86.52M
1.44%34.91M
23.59%52.42M
Free cash flow
72.52%-4.58M
105.20%3.82M
245.49%16.19M
167.38%11.23M
58.68%-6.93M
42.24%-16.67M
41.68%-73.42M
70.04%-11.13M
-2.87%-16.67M
54.35%-16.77M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 84.94%-2.22M114.79%8.8M338.46%17.6M190.22%11.99M52.79%-6.06M43.40%-14.72M47.04%-59.51M77.95%-7.38M0.95%-13.28M60.23%-12.83M
Net income from continuing operations 362.28%17.81M57.15%-28.24M-44.25%-17.64M117.22%2.57M53.72%-6.37M72.85%-6.79M8.02%-65.9M26.54%-12.23M15.88%-14.9M27.19%-13.76M
Operating gains losses 27.78%23K271.37%26.36M6,168.96%26.25M1,509.20%92.85K-84.95%96-99.73%18K3,111.31%7.1M197.93%418.65K146.16%5.77K-99.18%638
Depreciation and amortization 3.98%2.11M17.14%8.33M8.90%2.11M12.38%2.09M21.65%2.1M27.84%2.03M29.42%7.11M27.55%1.94M30.93%1.86M30.04%1.72M
Other non cash items -84.85%217K19.59%6.29M7.52%1.54M-12.78%1.68M21.10%1.64M160.77%1.43M199.71%5.26M206.66%1.43M327.20%1.92M215.45%1.35M
Change In working capital -95.73%-24.52M44.64%-10.12M99,563.79%3.6M210.66%3.86M-51.76%-5.06M-9.33%-12.53M64.62%-18.29M99.98%-3.62K-300.87%-3.49M79.15%-3.33M
-Change in receivables -101.58%-22.2M-191.16%-11.92M-27.79%3.9M368.16%5.41M-251.41%-10.21M-473.67%-11.01M185.22%13.07M165.95%5.4M-164.04%-2.02M182.44%6.75M
-Change in inventory -584.54%-4.83M75.03%-9.63M-2,571.51%-9.79M92.07%-1.34M131.82%2.2M95.11%-705K10.73%-38.56M96.54%-366.46K-16.74%-16.84M-24.77%-6.93M
-Change in prepaid assets -39.20%611K232.65%841K919.33%2.07M84.32%-72.39K-264.90%-2.17M361.82%1.01M79.34%-634K-63.53%203.48K44.12%-461.58K-832.77%-593.52K
-Change in payables and accrued expense 174.92%1.22M36.42%11.37M249.94%7.65M-99.21%126.09K316.33%5.22M-1,711.76%-1.63M-14.06%8.33M-150.28%-5.1M16.67%15.94M-11.63%-2.41M
-Change in other current liabilities 462.03%677K-57.57%-791K-68.14%-229.66K-143.01%-268.34K26.35%-106.01K-68.37%-187K-329.22%-502K-222.55%-136.59K-163.63%-110.42K-341.89%-143.93K
Cash from discontinued investing activities
Operating cash flow 84.94%-2.22M114.79%8.8M338.46%17.6M190.22%11.99M52.79%-6.06M43.40%-14.72M47.04%-59.51M77.95%-7.38M0.95%-13.28M60.23%-12.83M
Investing cash flow
Cash flow from continuing investing activities -21.44%-2.36M64.19%-4.98M62.46%-1.41M77.62%-756.56K77.86%-872.23K31.56%-1.95M-2.96%-13.91M-1.98%-3.75M-21.22%-3.38M11.96%-3.94M
Net PPE purchase and sale -20.67%-2.35M65.70%-4.77M68.06%-1.2M77.62%-756.56K77.86%-872.23K31.56%-1.95M-2.96%-13.91M-1.98%-3.75M-21.22%-3.38M11.96%-3.94M
Net intangibles purchase and sale ---15K---210K--------------0--0------------
Cash from discontinued investing activities
Investing cash flow -21.44%-2.36M64.19%-4.98M62.46%-1.41M77.62%-756.56K77.86%-872.23K31.56%-1.95M-2.96%-13.91M-1.98%-3.75M-21.22%-3.38M11.96%-3.94M
Financing cash flow
Cash flow from continuing financing activities -122.62%-1.45M-135.82%-38.99M-162.15%-38.99M149.22%415.36K175.10%239.61K-101.38%-650K-10.08%108.85M16.58%62.74M-110.29%-843.79K-101.86%-319.04K
Net issuance payments of debt --0-145.64%-23.6M-270,400.88%-23.58M--033.71%-6.03K-100.02%-10K152,200.00%51.71M-2.66%-8.72K-6.94%-9.25K-6.98%-9.09K
Net common stock issuance ------0-----------------46.64%64.65M------------
Proceeds from stock option exercised by employees --1.03M530.86%1.1M-95.17%8.46K--623.99K--471.55K--0--175K--175K--0----
Net other financing activities -286.88%-2.48M-114.68%-16.49M-645.61%-15.42M75.00%-208.64K27.11%-225.91K85.68%-640K-12,290.32%-7.68M-514,271.89%-2.07M-36,390.77%-834.54K---309.95K
Cash from discontinued financing activities
Financing cash flow -122.62%-1.45M-135.82%-38.99M-162.15%-38.99M149.22%415.36K175.10%239.61K-101.38%-650K-10.08%108.85M16.58%62.74M-110.29%-843.79K-101.86%-319.04K
Net cash flow
Beginning cash position -40.65%51.35M69.36%86.52M112.45%74.16M19.27%62.51M-0.43%69.2M69.36%86.52M-8.64%51.09M1.44%34.91M23.59%52.42M12.17%69.5M
Current changes in cash 65.20%-6.03M-199.26%-35.17M-144.18%-22.81M166.50%11.64M60.85%-6.69M-194.04%-17.32M833.30%35.43M209.48%51.62M-118.91%-17.51M12.61%-17.09M
End cash Position -34.51%45.33M-40.65%51.35M-40.65%51.35M112.45%74.16M19.27%62.51M-0.43%69.2M69.36%86.52M69.36%86.52M1.44%34.91M23.59%52.42M
Free cash flow 72.52%-4.58M105.20%3.82M245.49%16.19M167.38%11.23M58.68%-6.93M42.24%-16.67M41.68%-73.42M70.04%-11.13M-2.87%-16.67M54.35%-16.77M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg